Drugs & Aging

, Volume 5, Issue 1, pp 1–7 | Cite as

Helicobacter pylori Infection

Implications for Ulcer Therapy in Older Patients
  • Martin Buckley
  • Paul Martin
  • Colm O’Morain
Leading Article


Gastric Cancer Gastritis Duodenal Ulcer Gastric Ulcer Pylorus Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jones DM, Eldridge J, Fox AJ, et al. Antibody to the gastric campylobacter-like organism, clinical correlations and distribution in the normal population. J Med Microbiol 1986; 22: 57–62PubMedCrossRefGoogle Scholar
  2. 2.
    Perez-Perez GI, Dworkin BM, Chodos JE, et al. Camplyobacter pylori antibodies in humans. Ann Intern Med 1988; 109: 11–7PubMedGoogle Scholar
  3. 3.
    Kuipers EJ, Pena AS, van Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993; 342: 328–31PubMedCrossRefGoogle Scholar
  4. 4.
    Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233–5PubMedCrossRefGoogle Scholar
  5. 5.
    George LL, Borody TJ, Andrews P, et al. Cure of duodenal ulcer relapse after eradication of Helicobacter pylori. Med J Aust 1990; 153: 145–9PubMedGoogle Scholar
  6. 6.
    Oderda G, Vaira D, Ainley C, et al. Eighteen months follow-up of Helicobacter pylori positive children treated with amoxycillin and tinidazole. Gut 1992; 33: 1328–30PubMedCrossRefGoogle Scholar
  7. 7.
    Drumm B, Perez-Perez G, Blazer M, et al. Intra-familial clustering of Campylobacter pylori infection. N Engl J Med 1990; 312: 359–63CrossRefGoogle Scholar
  8. 8.
    Strickland RG, Mackay R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973; 8: 436Google Scholar
  9. 9.
    Marshall BJ, Armstrong JA, McGechnie DB, et al. Attempt to fulfil Koch’s postulates for pyloric Campylobacter. Med J Aust 1985; 142:436–9PubMedGoogle Scholar
  10. 10.
    O’Riordan TG, Tobin A, O’Morain C. Helicobacter pylori in elderly dyspeptic patients. Age Ageing 1991; 20: 189–92PubMedCrossRefGoogle Scholar
  11. 11.
    Morris J, Dew M. Age and gastrointestinal disease. In: Pathy MJ, editor. Principles and practice of geriatric medicine. London: J Wiley and Sons, 1985; 297–352Google Scholar
  12. 12.
    Nyren O, Adami H, Gustavsson S, et al. Social and economic costs of non-ulcer dyspepsia. Scand J Gastroenterol 1985; 209 (Suppl.): 41–7CrossRefGoogle Scholar
  13. 13.
    Vaira D, Miglioli M, Menegatti M, et al. Endoscopic findings in 296 asymptomatic blood donors according to high levels of IgG to Helicobacter pylori [abstract]. Acta Gastroenterol Belg 1993; 56 (Suppl.): 49Google Scholar
  14. 14.
    Krag E. The pseudo-ulcer syndrome: a clinical, radiographic and statistical follow-up study of patients with ulcer symptoms but no demonstrable ulcer in the stomach or duodenum. Dan Med Bull 1969; 16: 6–9PubMedGoogle Scholar
  15. 15.
    Coghlan JG, Gilligan D, Humphries H, et al. Campylobacter pylori and recurrence of duodenal ulcers; a 12 month follow-up study. Lancet 1987; 2: 1109–11PubMedCrossRefGoogle Scholar
  16. 16.
    Marshall BJ, Goodwin CS, Warren RJ, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42PubMedCrossRefGoogle Scholar
  17. 17.
    Smith AC, Price AB, Boriello P, et al. Acomparison of ranitidine and tripotassium dicitratobismuthate in relapse rates of duodenal ulcer. The role of Campylobacter pylori [abstract]. Gastroenterol 1988; 94: 431Google Scholar
  18. 18.
    George L, Hyland L, Morgan A, et al. Smoking does not contribute to duodenal ulcer relapse after eradication [abstract]. Gastroenterol 1990; 98: 48Google Scholar
  19. 19.
    Oderda G, Forni M, Dell’Olio D, et al. Cure of peptic ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 1: 1599CrossRefGoogle Scholar
  20. 20.
    Patchett S, O’Riordan TO, Leen E, et al. A prospective study of Helicobacter pylori eradication in duodenal ulcer [abstract]. Gastroenterol 1990; 98: 104Google Scholar
  21. 21.
    Hentschel E, Nemec H, Schutze K, et al. Duodenal ulcer recurrences and Helicobacter pylori. Lancet 1991; 338: 569PubMedCrossRefGoogle Scholar
  22. 22.
    Hepps KS, Ramirez FC, Lew GM, et al. Treatment of Helicobacter pylori reduces the rate of rebleeding in complicated peptic ulcer disease. Gastrointest Endosc 1992; 38: 234Google Scholar
  23. 23.
    Dixon MF. Helicobacter pylori and peptic ulceration; histopathological aspects. J Gastroenterol Hepatol 1991; 6: 125–30PubMedCrossRefGoogle Scholar
  24. 24.
    Rauws EAJ, Tytgat GNJ, editors. Campylobacter pylori. Amsterdam: W.C. den Ouden BV, 1989: 23–7Google Scholar
  25. 25.
    Sobala GM, King RFG, Axon ATR, et al. Reflux gastritis in the intact stomach. J Clin Pathol 1990; 43: 303–6PubMedCrossRefGoogle Scholar
  26. 26.
    Sobala GM, O’Connor HJ, Dewar EP, et al. Histological consequences of bile reflux on the gastric mucosa, with special reference to intestinal metaplasia. J Clin Pathol. In pressGoogle Scholar
  27. 27.
    Correa P, Cuello C, Fajardo LF, et al. Diet and gastric cancer: nutritional survey in a high-risk area. J Natl Cancer Inst 1983; 70: 673–8PubMedGoogle Scholar
  28. 28.
    Tatsuta M, Iishi H, Okuda S. Effect of cigarette smoking on acid-secreting area and intestinal metaplasia in the stomach. Dig Dis Sci 1988; 33: 23–9PubMedCrossRefGoogle Scholar
  29. 29.
    Kimura K. Chronological transition of the fundic-pyloric border determined by step-wise biopsy of the lesser and greater curvatures of the stomach. Gastroenterol 1972; 63: 584–92Google Scholar
  30. 30.
    Tatsuta M, Okuda S. Location, healing and recurrence of gastric ulcers in relation to fundal gastritis. Gastroenterol 1975; 69: 897–902Google Scholar
  31. 31.
    Niemela S, Sotka M, Seppola K, et al. A double-blind study to compare the efficacy of De-Nol in combination with metro-nidazole versus De-Nol or ranitidine in combination with metronidazole placebo in the treatment of gastric ulcers. Ital J Gastroenterol 1991; 23Suppl. 2: 112Google Scholar
  32. 32.
    Farah D, Sturrock RD, Russell RI. Peptic ulcer disease in rheumatoid arthritis. Ann Rheum Dis 1988; 47: 478–80PubMedCrossRefGoogle Scholar
  33. 33.
    Guarner J, Mohar A, Parsonnet J, et al. The association of Helicobacter pylori with gastric cancer and preneoplastic lesions in Chiapas, Mexico. Cancer 1993; 71: 297–301PubMedCrossRefGoogle Scholar
  34. 34.
    Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132–6PubMedCrossRefGoogle Scholar
  35. 35.
    Forman D, Newell DG, Fullerton F, et al. Association between Helicobacter pylori and the risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302: 1302–5PubMedCrossRefGoogle Scholar
  36. 36.
    Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31PubMedCrossRefGoogle Scholar
  37. 37.
    Eurogast Study Group. An international association between Helicobacter pylori and gastric cancer. Lancet 1993; 341: 1359–62CrossRefGoogle Scholar
  38. 38.
    Graham DY, Klein PD, Evans DG, et al. Helicobacter pylori: epidemiology, relationship to gastric cancer and the role of infants in transmission. Eur J Gastroenterol Hepatol 1992; 4Suppl. 1: S1–S6Google Scholar
  39. 39.
    The Gastrointestinal Physiology Working Group. Helicobacter pylori and gastritis in Peruvian patients: relationship to socio-economic level, age and sex. Am J Gastroenterol 1990; 85: 819–23Google Scholar
  40. 40.
    Sobala GM, Schorah CJ, Sanderson M, et al. Ascorbic acid in the human stomach. Gastroenterology 1989; 97: 357–63PubMedGoogle Scholar
  41. 41.
    Sobala GM, Pignatelli B, Schorah CJ, et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 1991; 12: 193–8PubMedCrossRefGoogle Scholar
  42. 42.
    Sobala GM, Schorah CJ, Shires S, et al. Impairment of gastric ascorbic acid concentration by acute Helicobacter pylori infection. Gut 1990; 31: A1180Google Scholar
  43. 43.
    Sobala GM, Schorah CJ, Shires S, et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993; 34: 1038–41PubMedCrossRefGoogle Scholar
  44. 44.
    Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 355–6Google Scholar
  45. 45.
    Cahill RJ, Beattie S, Hamilton H, et al. Cell proliferation in the progression from normal mucosa to gastric carcinoma. Acta Gastroenterol Belg 1993; 56 (Suppl.): 61Google Scholar
  46. 46.
    Wotherspoon AC, Oritz-Hidalgo C, Falzon MF, et al. Helicobacter pylori and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175–6PubMedCrossRefGoogle Scholar
  47. 47.
    Wotherspoon AC, Doglini C, Diss TC, et al. Regression of primary low grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacterpylori. Lancet 1993; 342: 575–7PubMedCrossRefGoogle Scholar
  48. 48.
    Borody TJ. Possibilities for Helicobacter pylori suppression/eradication. Eur J Gastroenterol Hepatol 1992; 4Suppl. 2: S37–S40Google Scholar
  49. 49.
    Chiba N, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol. In press.Google Scholar
  50. 50.
    Graham DY, Lew GM, Maluty HM, et al. Factors influencing the eradication of H. pylori with triple therapy. Gastroenterol 1992; 102: 493–6Google Scholar
  51. 51.
    Labenz J, Gyenes E, Ruhl GH, et al. Amoxycillin-omeprazole treatment for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3Suppl. 1: S10Google Scholar
  52. 52.
    Bayerdorffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxycillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 697–702Google Scholar
  53. 53.
    Wyeth JW, Pounder RE, De Koster E, et al. Ranitidine bismuth citrate with antibiotics for eradication of Helicobacter pylori [abstract]. Gastroenterology 1993; 104: A804Google Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • Martin Buckley
    • 1
  • Paul Martin
    • 1
  • Colm O’Morain
    • 1
  1. 1.Department of Gastroenterology, Meath/Adelaide HospitalsTrinity CollegeDublin 8Ireland

Personalised recommendations